4 completed. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 2 | Completed 2 |
Follow Latent Infection: new trials by email Literature Review of Latent Infection trials Research Report on Latent Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tuberculosis Clinical Trials Consortium Study 35 Rifapentine, Isoniazid - Latent Tuberculosis | Phase 1 / Phase 2 | Completed | Centers for Disease Control and Prevention | 69 | 2019-11-12 | 2026-07-24 |
| 2R2: Higher Dose Rifampin for 2 Months vs Standard Dose Rifampin for Latent TB. Rifampin double dose, Rifampin triple dose, Rifampin standard dose - Latent Tuberculosis | Phase 2 | Completed | McGill University Health Centre/Research Institute of the McGill University Health Centre | 1368 | 2019-09-20 | 2026-04-13 |
| A Phase I/IIa AERAS-456 in HIV-Negative Adults With & Without Latent Tuberculosis Infection (C-035-456) H56ug/IC31nmol, Placebo - Latent Tuberculosis Bacteriology and Histology Unknown, Latent Tuberculosis | Phase 1 / Phase 2 | Completed | Aeras | 98 | 2013-08-01 | 2019-12-19 |
| Clinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI® Following One Month of Isoniazid Treatment in Subjects With Latent Tuberculosis Infection RUTI, RUTI Matching Placebo - Latent Tuberculosis Infection, Tuberculosis | Phase 2 | Completed | Archivel Farma S.L. | 95 | 2010-06-01 | 2013-01-24 |
Latent Tuberculosis (4) · Tuberculosis (1)
Actinomycetales Infections (4) · Bacterial Infections (4) · Bacterial Infections and Mycoses (4) · Gram-Positive Bacterial Infections (4) · Infections (4) · Mycobacterium Infections (4) · Tuberculosis (3)
Isoniazid (1) · Rifampin (1) · rifapentine (1)
Aeras (1) · Archivel Farma S.L. (1) · Centers for Disease Control and Prevention (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1)
South Africa (3) · Canada (1) · Indonesia (1) · Vietnam (1)
Angelique Luabeya, MD (1) · Anneke Hesseling, MD (1) · Avy Violari, MD (1) · Dereck Tait, MD (1) · Dick Menzies (1) · Mark Cotton, MD (1) · Pere Joan Cardona, MD, PhD (1)
PMID 24586912, PMID 30092143, PMID 36730240, PMID 38552659, PMID 41504451